Word: ppl
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...even conceivable that a human with a failing liver could have a new one grown from, say, a cell taken out of his bone marrow. "This is fantasy now," admits Alan Colman, research director of PPL Therapeutics, the Scottish biotechnology firm that holds the license for the process that created Dolly. "But two years ago, so was the work that is now being presented in Nature...
From the people that brought you Dolly the Sheep and the people that brought you 50 cloned mice comes a new project: genetically engineered pigs. PPL Therapeutics in Edinburgh, Scotland, is teaming up with ProBio America for the potentially lucrative purpose of cloning pigs for animal-to-human transplants. "We are going to see if we can make their technique -- the Honolulu technique, used with mice -- work with pigs," said PPL chief Dr. Ron James...
Nobody at Roslin or PPL is talking about cloning humans. Even if they were, their procedure is obviously not practical--not as long as dozens of surrogates need to be impregnated for each successful birth. And that is probably a good thing, because it gives the public time to digest the news--and policymakers time to find ways to prevent abuses without blocking scientific progress. If the policymakers succeed, and if their guidelines win international acceptance, it may take a lot longer than the editorial writers and talk-show hosts think before a human clone emerges--even from the shadows...
...average biotech stock has doubled in two years and reached a four-year high. Following the cloning news out of Scotland, investors indiscriminately bid up stocks of cloning companies. Shares of PPL Therapeutics of Edinburgh, which helped fund the sheep-cloning research, jumped 16% in a day. There have been some genuine commercial successes, such as Biogen Inc.'s drug Avonex, approved last year to treat multiple sclerosis. Still, a dangerous froth is forming. "During the next six months you're going to see quite a few disasters," predicts Evan Sturza of Sturza's Medical Investment Letter...
...PPL retains the rights to the technique, which allows them to recover pharmacologically-significant proteins out of clones' milk. The company has applied for additional patents and retains the agricultural rights to the techniques...